290 related articles for article (PubMed ID: 18512759)
41. Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity.
Sun KH; Chang KH; Clawson S; Ghosh S; Mirzaei H; Regnier F; Shah K
J Neurochem; 2011 Sep; 118(5):902-14. PubMed ID: 21668448
[TBL] [Abstract][Full Text] [Related]
42. Activation of cyclin-dependent kinase 5 (Cdk5) in primary sensory and dorsal horn neurons by peripheral inflammation contributes to heat hyperalgesia.
Yang YR; He Y; Zhang Y; Li Y; Li Y; Han Y; Zhu H; Wang Y
Pain; 2007 Jan; 127(1-2):109-20. PubMed ID: 16996690
[TBL] [Abstract][Full Text] [Related]
43. Involvement of cyclin dependent kinase 5 and its activator p35 in staurosporine-induced apoptosis of cortical neurons.
Zhang BF; Peng FF; Zhang W; Shen H; Wu SB; Wu DC
Acta Pharmacol Sin; 2004 Sep; 25(9):1105-11. PubMed ID: 15339383
[TBL] [Abstract][Full Text] [Related]
44. Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides.
Lopes JP; Oliveira CR; Agostinho P
Cell Cycle; 2009 Jan; 8(1):97-104. PubMed ID: 19158499
[TBL] [Abstract][Full Text] [Related]
45. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.
Kobayashi H; Saito T; Sato K; Furusawa K; Hosokawa T; Tsutsumi K; Asada A; Kamada S; Ohshima T; Hisanaga S
J Biol Chem; 2014 Jul; 289(28):19627-36. PubMed ID: 24872417
[TBL] [Abstract][Full Text] [Related]
46. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
[TBL] [Abstract][Full Text] [Related]
47. Role of caspases, calpain and cdk5 in ammonia-induced cell death in developing brain cells.
Cagnon L; Braissant O
Neurobiol Dis; 2008 Nov; 32(2):281-92. PubMed ID: 18722528
[TBL] [Abstract][Full Text] [Related]
48. CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.
Quan Q; Qian Y; Li X; Li M
J Alzheimers Dis; 2019; 71(2):443-460. PubMed ID: 31403945
[TBL] [Abstract][Full Text] [Related]
49. The inhibition of Cdk5 activity after hypoxia/ischemia injury reduces infarct size and promotes functional recovery in neonatal rats.
Tan X; Chen Y; Li J; Li X; Miao Z; Xin N; Zhu J; Ge W; Feng Y; Xu X
Neuroscience; 2015 Apr; 290():552-60. PubMed ID: 25665755
[TBL] [Abstract][Full Text] [Related]
50. Neurotoxicity induces cleavage of p35 to p25 by calpain.
Lee MS; Kwon YT; Li M; Peng J; Friedlander RM; Tsai LH
Nature; 2000 May; 405(6784):360-4. PubMed ID: 10830966
[TBL] [Abstract][Full Text] [Related]
51. [Ginsenoside Rb1 attenuates beta-amyloid peptide(25-35) -induced hyperphosphorylation of tau protein through CDK5 signal pathway].
Xie YH; Chen XC; Zhang J; Huang TW; Song JQ; Fang YX; Pan XD; Lin ZY
Yao Xue Xue Bao; 2007 Aug; 42(8):828-32. PubMed ID: 17944229
[TBL] [Abstract][Full Text] [Related]
52. Cdk5/p25 specific inhibitory peptide TFP5 rescues the loss of dopaminergic neurons in a sub-acute MPTP induced PD mouse model.
Zhang Q; Xie H; Ji Z; He R; Xu M; He Y; Huang J; Pan S; Hu Y
Neurosci Lett; 2016 Oct; 632():1-7. PubMed ID: 27542341
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease.
Alvira D; Tajes M; Verdaguer E; Acuña-Castroviejo D; Folch J; Camins A; Pallas M
J Pineal Res; 2006 Apr; 40(3):251-8. PubMed ID: 16499562
[TBL] [Abstract][Full Text] [Related]
54. Cdk5 interacts with Hif-1α in neurons: a new hypoxic signalling mechanism?
Antoniou X; Gassmann M; Ogunshola OO
Brain Res; 2011 Mar; 1381():1-10. PubMed ID: 20977891
[TBL] [Abstract][Full Text] [Related]
55. Role of CDK5 in neuroprotection from serum deprivation by mu-opioid receptor agonist.
Wang Y; Xie WY; He Y; Wang M; Yang YR; Zhang Y; Yin DM; Jordan-Sciutto KL; Han JS; Wang Y
Exp Neurol; 2006 Dec; 202(2):313-23. PubMed ID: 16879821
[TBL] [Abstract][Full Text] [Related]
56. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.
Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH
J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463
[TBL] [Abstract][Full Text] [Related]
57. TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity.
Binukumar BK; Zheng YL; Shukla V; Amin ND; Grant P; Pant HC
J Alzheimers Dis; 2014; 39(4):899-909. PubMed ID: 24326517
[TBL] [Abstract][Full Text] [Related]
58. Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase.
Kwon YT; Gupta A; Zhou Y; Nikolic M; Tsai LH
Curr Biol; 2000 Apr; 10(7):363-72. PubMed ID: 10753743
[TBL] [Abstract][Full Text] [Related]
59. Cyclin-dependent kinase 5 activity regulates pain signaling.
Pareek TK; Keller J; Kesavapany S; Pant HC; Iadarola MJ; Brady RO; Kulkarni AB
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):791-6. PubMed ID: 16407116
[TBL] [Abstract][Full Text] [Related]
60. Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity.
Wang Y; White MG; Akay C; Chodroff RA; Robinson J; Lindl KA; Dichter MA; Qian Y; Mao Z; Kolson DL; Jordan-Sciutto KL
J Neurochem; 2007 Oct; 103(2):439-55. PubMed ID: 17897354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
